This study reveals how anamorelin, a superagonist targeting the ghrelin receptor, works compared to other drugs. Structural insights into ligand binding and genetic variations offer a framework for personalized therapies
- Yuki Shiimura
- Dohyun Im
- Ikuo Masuho